Autopsy report · NCT04631211

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

“This study was terminated due to loss of funding for this indication from the Biomedical Advanced Research and Development Authority (BARDA) in November 2022.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 10 months before it stopped.
• 21 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Cellphire Therapeutics, Inc.

Sponsor type

Industry

Conditions

Thrombocytopenia; Hematologic Malignancy; Bone Marrow Aplasia; Myeloproliferative Disorders; Myelodysplastic Syndromes; Platelet Refractoriness

Interventions

Thrombosomes; Liquid Stored Platelets (LSP)

Participants

21

Sites

6

Countries

Israel, Norway, United States

Trials that died the same way

• Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel
  “Funding has been terminated for this study.” (73% match in meaning)
• A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
  “Study terminated due to various reasons impacting the feasibility of future clinical development” (71% match in meaning)
• Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)
  “Funding for this study has been discontinued.” (71% match in meaning)
• Therapeutic Exercise in Patients With Hemophilia
  “The Study was terminated due to lack of funding for continuing” (70% match in meaning)
• Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer
  “The study was terminated due to futility and lack of future funding” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.